UBH BELLAIRE HOSPPITAL — History
CCN 454107 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$28M
Latest Revenue (FY2022)
+6.5%
Revenue CAGR (3yr)
7.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $26M | $28M | +7.0% | +6.5% |
| Operating Expenses | $22M | $22M | $26M | +13.5% | +6.5% |
| Operating Margin | 7.6% | 12.9% | 7.6% | -41.1% | -0.0% |
| Net Income | $2M | $3M | $2M | -37.0% | +6.5% |
| Licensed Beds | 122 | 122 | 122 | +0.0% | +0.0% |
| Total Patient Days | 34,290 | 34,891 | 34,730 | -0.5% | +0.6% |
| Medicare Day % | 15% | 11% | 11% | -5.5% | -15.0% |
| Medicaid Day % | 0% | 0% | 0% | +19.1% | -38.7% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.5% ($24M → $28M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.5%
This Hospital
+7.6%
State Avg
Latest Margin
7.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | 7.6% |
| FY2024 (proj) | $31M | 7.6% |
| FY2025 (proj) | $33M | 7.6% |